UNSPSC 51341604: Rimantadine hydrochloride

This classification denotes a pegylated interferon alfa with the molecular formula C10H18N3O5(C2H4O)N(C2H4O)N, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier Q46947FE7K. European Medicines Agency schedules peginterferon alfa-2a in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB16452MIG. The term peginterferon alfa-2a is a European Medicines Agency European Public Assessment Report System designation. Most nations schedule rimantadine hydrochloride under HS 29213099 and SITC 51453.

As of Q4 2014, RIMANTADINE HYDROCHLORIDE remains the US FDA Preferred Term for this commodity. Rimantadine hydrochloride bears US NLM identifiers UMLS ID C0733408 and NCI Concept Code C61928. SMILES: NONE.

UNSPSC 51341604 Rimantadine hydrochloride is a Commodity code that nominally covers a specific antiviral pharmaceutical, yet the most recent state and local opportunities posted under this code show little activity directly aligned with rimantadine procurement. The Illinois Department of Public Health and Seminole County, Florida have each posted pharmaceutical-related solicitations recently, but neither targets rimantadine. The Illinois posting on August 28, 2026 awarded a piggyback contract through the MMCAP Infuse consortium to Chartwell Rx LLC for warehouse supply of Doxycycline Hyclate 100mg tablets and Ciprofloxacin Hydrochloride 500mg tablets—antibiotics, not antivirals—under a $2,999,999.11 three-year agreement. Seminole County's June 30, 2026 Invitation for Bid solicited 1,900 units of Naloxone and 800 Safe Drug Deactivation Systems annually for community health initiatives, again outside the rimantadine scope. State and local health departments and county public-health jurisdictions represent the typical issuing bodies when pharmaceutical procurement does occur under related codes, but the code shows minimal recent targeting of rimantadine specifically.

Geographic activity is concentrated in Florida and Illinois based on the recent postings, though the code itself does not show robust state and local solicitation volume for this particular pharmaceutical. The Illinois award to Chartwell Rx LLC delivered to Springfield, and the Seminole County bid required quarterly deliveries to the Community Health Building in Sanford, Florida. No open solicitations for rimantadine hydrochloride appear in the recent-opportunities block, and no information on renewal pipeline activity or anticipated volume supports a forward outlook. Businesses evaluating pursuit under this code should confirm whether state and local health agencies in their target markets maintain standing demand for rimantadine or whether the code tagging reflects residual inventory-management categories rather than active procurement signals.